Santa Barbara Hospital Pioneers Non-Invasive Liver Tumor Treatment with Histotripsy
Table of Contents
A groundbreaking new treatment option for liver tumors is now available on the Central Coast, offering hope to patients who may not be eligible for traditional surgery. Santa Barbara Cottage Hospital (SBCH) is the sole provider of histotripsy between Southern and Northern California, and one of only a few hospitals nationwide offering this innovative approach.
Histotripsy represents a significant advancement in the fight against both cancerous and benign liver tumors. The FDA-approved procedure utilizes focused ultrasound energy to precisely destroy targeted tissue, offering a non-invasive alternative to more aggressive interventions.
How Histotripsy Works: A Targeted Approach
Unlike traditional surgical methods, histotripsy avoids the risks associated with radiation, heat, incisions, and needles. The process leverages advanced imaging and high-pitched ultrasound waves to pinpoint tumorous tissue within the liver. These sound waves generate microscopic, controlled bubbles inside the tumor. When these bubbles rapidly collapse, they selectively break apart the targeted tissue, leaving the surrounding healthy tissue completely unharmed.
The body’s natural immune system then clears away the broken-down tissue, completing the treatment process. Remarkably, this precise intervention can often be completed during a single outpatient visit.
Expanding Treatment Options for Complex Cases
“Histotripsy allows us to offer a non-invasive method for treating liver tumors that may be difficult to access surgically or with other technologies,” said Dr. Elliot DeYoung, an interventional radiologist at SBCH. “Having this technology available broadens our ability to personalize care and pursue the best possible outcomes for each patient.”
This therapy is particularly valuable for patients whose tumors are located near vital structures, making surgical removal too risky. The non-invasive nature of histotripsy allows for precise targeting of difficult-to-reach tumors while minimizing the potential for complications.
Determining Candidacy for Histotripsy
While histotripsy offers a promising new avenue for liver tumor treatment, it is not universally suitable. Eligibility for the procedure depends on several factors, including the size and location of the tumor. Patients interested in exploring histotripsy as a treatment option should consult with their physician for a comprehensive evaluation.
This innovative treatment underscores SBCH’s commitment to providing cutting-edge medical care and expanding access to advanced therapies for patients throughout the region.
